{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:45:37Z","timestamp":1793087137218,"version":"4.5.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:00:00Z","timestamp":1448409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0143685","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T18:45:49Z","timestamp":1448477149000},"page":"e0143685","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK\/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells"],"prefix":"10.1371","volume":"10","author":[{"given":"Cody","family":"Paiva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Claire","family":"Godbersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Soderquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumner","family":"Kilmarx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Spurgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreesha P.","family":"Srinivasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey V.","family":"Danilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1182\/blood-2007-12-129379","article-title":"Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century","volume":"111","author":"H Brenner","year":"2008","journal-title":"Blood"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood-2013-09-453092","article-title":"How will B-cell-receptor-targeted therapies change future CLL therapy?","volume":"123","author":"JA Jones","year":"2014","journal-title":"Blood"},{"key":"ref3","article-title":"Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib","author":"JA Woyach","year":"2014","journal-title":"The New England journal of medicine"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/bjh.13042","article-title":"A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53","volume":"167","author":"P Shindiapina","year":"2014","journal-title":"British journal of haematology"},{"key":"ref5","article-title":"Three-year follow-up of treatment-naive and previously treated patients with CLL and SLL receiving single-agent ibrutinib","author":"JC Byrd","year":"2015","journal-title":"Blood"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"M Malumbres","year":"2009","journal-title":"Nature reviews Cancer"},{"issue":"11\u201312","key":"ref7","first-page":"7","article-title":"The CDK network: linking cycles of cell division and gene expression","volume":"3","author":"RP Fisher","year":"2012","journal-title":"Genes Cancer"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI23409","article-title":"In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells","volume":"115","author":"BT Messmer","year":"2005","journal-title":"The Journal of clinical investigation"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1586\/14737140.2013.825424","article-title":"Toward a cure for chronic lymphocytic leukemia: an attack on multiple fronts","volume":"13","author":"AV Danilov","year":"2013","journal-title":"Expert Rev Anticancer Ther"},{"issue":"Pt 22","key":"ref10","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1242\/jcs.02718","article-title":"Secrets of a double agent: CDK7 in cell-cycle control and transcription","volume":"118","author":"RP Fisher","year":"2005","journal-title":"Journal of cell science"},{"key":"ref11","article-title":"Regulation of CDK9 activity by phosphorylation and dephosphorylation","author":"S Nekhai","year":"2014","journal-title":"Biomed Res Int"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.tips.2008.03.003","article-title":"Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology","volume":"29","author":"S Wang","year":"2008","journal-title":"Trends in pharmacological sciences"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.leu.2403295","article-title":"Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cells","volume":"18","author":"IN Hahntow","year":"2004","journal-title":"Leukemia"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/ijc.26127","article-title":"CDKI-71, a novel CDK9 inhibitor, is preferentially cytotoxic to cancer cells compared to flavopiridol","volume":"130","author":"X Liu","year":"2012","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1182\/blood-2005-04-1678","article-title":"Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death","volume":"106","author":"R Chen","year":"2005","journal-title":"Blood"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1182\/blood.V96.2.393","article-title":"Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia","volume":"96","author":"S Kitada","year":"2000","journal-title":"Blood"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2011-12-400184","article-title":"ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol","volume":"120","author":"E Mahoney","year":"2012","journal-title":"Blood"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1158\/1078-0432.CCR-12-2170","article-title":"Inhibition of NF-kappaB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes prosurvival stimuli to induce apoptosis in chronic lymphocytic leukemia cells","volume":"19","author":"E Cosimo","year":"2013","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/leu.2012.144","article-title":"The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells","volume":"26","author":"AJ Johnson","year":"2012","journal-title":"Leukemia"},{"issue":"34","key":"ref20","doi-asserted-by":"crossref","first-page":"31793","DOI":"10.1074\/jbc.M102306200","article-title":"Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo","volume":"276","author":"SH Chao","year":"2001","journal-title":"The Journal of biological chemistry"},{"issue":"35","key":"ref21","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1200\/JCO.2009.22.6944","article-title":"Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease","volume":"27","author":"TS Lin","year":"2009","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1158\/1535-7163.MCT-10-0324","article-title":"Dinaciclib (SCH 727965), a novel and potent cyclin-dependent kinase inhibitor","volume":"9","author":"D Parry","year":"2010","journal-title":"Molecular cancer therapeutics"},{"key":"ref23","article-title":"Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia","author":"J Flynn","year":"2015","journal-title":"Leukemia"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Joshi K, Padgaonkar A, Rathos M, Wagh V, Monohar S, Bhatia D, et al., editors. P1446A-05: A new oral cyclin-dependent kinase inhibitor with potent preclinical antitumor activity. AACR Annual Meeting; 2012; Chicago, IL, USA: Cancer Research.","DOI":"10.1158\/1538-7445.AM2012-3054"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Hao D, Chu Q, Welch S, Yau C, Spratlin J, Tang P, et al. A phase I and pharmacokinetic (PK) study of continuous daily administration of P1446A-05, a potent and specific oral Cdk4 inhibitor. ASCO Annual Meeting. 2012.","DOI":"10.1200\/jco.2012.30.15_suppl.3013"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Gupta S, Jain M, Maru A, Nag S, Somani N, Mehta A, et al. A phase I study of selective cyclin dependent kinase inhibitor P1446A-05 administered on an intermittent schedule in patients with advanced refractory tumors. ASCO Annual Meeting. 2012.","DOI":"10.1200\/jco.2012.30.15_suppl.3011"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/intimm\/dxh377","article-title":"B cell proliferation following CD40 stimulation results in the expression and activation of Src protein tyrosine kinase","volume":"18","author":"S Neron","year":"2006","journal-title":"Int Immunol"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1158\/1078-0432.CCR-13-0987","article-title":"The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-kappaB activation and induces apoptosis in chronic lymphocytic leukemia B cells","volume":"20","author":"JC Godbersen","year":"2014","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/bjh.12580","article-title":"Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia","volume":"163","author":"LA Humphries","year":"2013","journal-title":"British journal of haematology"},{"issue":"10","key":"ref30","first-page":"12","article-title":"Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of Bcl-2 modulation or dependence on functional p53","volume":"92","author":"JC Byrd","year":"1998","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Godbersen JC, Agarwal V, Paiva C, Brown JR, Danilov AV. A Novel Cyclin Dependent Kinase Inhibitor P1446A Induces Apoptosis Of Chronic Lymphocytic Leukemia B Cells. American Society of Hematology Annual Meeting; 2013; New Orleans, LA: Blood.","DOI":"10.1182\/blood.V122.21.1636.1636"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","DOI":"10.1186\/1747-1028-7-10","article-title":"The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle","volume":"7","author":"SA Henley","year":"2012","journal-title":"Cell Div"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tibs.2012.10.007","article-title":"Deciphering the retinoblastoma protein phosphorylation code","volume":"38","author":"SM Rubin","year":"2013","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0959-437X(98)80057-9","article-title":"Control of pRB phosphorylation","volume":"8","author":"S Mittnacht","year":"1998","journal-title":"Curr Opin Genet Dev"},{"issue":"19","key":"ref35","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2009-03-212852","article-title":"Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells","volume":"114","author":"LS Chen","year":"2009","journal-title":"Blood"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2013-04-495366","article-title":"AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia","volume":"123","author":"EK Keeton","year":"2014","journal-title":"Blood"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.canlet.2008.05.045","article-title":"Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy","volume":"273","author":"J Luo","year":"2009","journal-title":"Cancer letters"},{"issue":"24","key":"ref38","first-page":"7","article-title":"Regulation of protein stability by GSK3 mediated phosphorylation","volume":"8","author":"C Xu","year":"2009","journal-title":"Cell Cycle"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1016\/j.bbamcr.2013.06.028","article-title":"ER stress-induced cell death mechanisms","volume":"1833","author":"R Sano","year":"2013","journal-title":"Biochimica et biophysica acta"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"C Hetz","year":"2012","journal-title":"Nature reviews Molecular cell biology"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"C Hetz","year":"2012","journal-title":"Nature reviews Molecular cell biology"},{"issue":"44","key":"ref42","doi-asserted-by":"crossref","first-page":"37033","DOI":"10.1074\/jbc.M506771200","article-title":"Recruitment of tumor necrosis factor receptor-associated factor family proteins to apoptosis signal-regulating kinase 1 signalosome is essential for oxidative stress-induced cell death","volume":"280","author":"T Noguchi","year":"2005","journal-title":"The Journal of biological chemistry"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1128\/MCB.20.6.2198-2208.2000","article-title":"Activation of Apoptosis Signal-Regulating Kinase 1 (ASK1) by Tumor Necrosis Factor Receptor-Associated Factor 2 Requires Prior Dissociation of the ASK1 Inhibitor Thioredoxin","volume":"20","author":"H Liu","year":"2000","journal-title":"Molecular and Cellular Biology"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/embo-reports\/kve046","article-title":"ASK1 is required for sustained activations of JNK\/p38 MAP kinases and apoptosis","volume":"2","author":"K Tobiume","year":"2001","journal-title":"EMBO Rep"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"e61438","DOI":"10.1371\/journal.pone.0061438","article-title":"Oppositional regulation of Noxa by JNK1 and JNK2 during apoptosis induced by proteasomal inhibitors","volume":"8","author":"S Pietkiewicz","year":"2013","journal-title":"PloS one"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/leu.2013.138","article-title":"Gossypol overcomes stroma-mediated resistance to the BCL2 inhibitor ABT-737 in chronic lymphocytic leukemia cells ex vivo","volume":"27","author":"R Soderquist","year":"2013","journal-title":"Leukemia"},{"issue":"17","key":"ref47","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1182\/blood-2012-02-414060","article-title":"Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia","volume":"120","author":"MS Davids","year":"2012","journal-title":"Blood"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.18632\/oncotarget.1568","article-title":"A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine","volume":"5","author":"EP Walsby","year":"2014","journal-title":"Oncotarget"},{"issue":"9","key":"ref49","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-13-2033","article-title":"Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia","volume":"74","author":"W Fiskus","year":"2014","journal-title":"Cancer research"},{"key":"ref50","article-title":"Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK","author":"S Krysov","year":"2014","journal-title":"Blood"},{"issue":"11","key":"ref51","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1101\/gad.992302","article-title":"ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats","volume":"16","author":"H Nishitoh","year":"2002","journal-title":"Genes & development"},{"issue":"5453","key":"ref52","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.287.5453.664","article-title":"Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1","volume":"287","author":"F Urano","year":"2000","journal-title":"Science"},{"issue":"8","key":"ref53","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/ncb1284","article-title":"Cdc2-cyclin E complexes regulate the G1\/S phase transition","volume":"7","author":"E Aleem","year":"2005","journal-title":"Nature cell biology"},{"issue":"8","key":"ref54","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1158\/1535-7163.MCT-12-1197","article-title":"Vinblastine rapidly induces NOXA and acutely sensitizes primary chronic lymphocytic leukemia cells to ABT-737","volume":"12","author":"DJ Bates","year":"2013","journal-title":"Molecular cancer therapeutics"},{"key":"ref55","article-title":"Vincristine activates c-Jun N-terminal kinase in chronic lymphocytic leukemia in vivo","author":"DJ Bates","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"ref56","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ncb3010","article-title":"DEPDC1\/LET-99 participates in an evolutionarily conserved pathway for anti-tubulin drug-induced apoptosis","volume":"16","author":"A Sendoel","year":"2014","journal-title":"Nature cell biology"},{"issue":"8","key":"ref57","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ncb3012","article-title":"Anti-tubulins DEPendably induce apoptosis","volume":"16","author":"DP Denning","year":"2014","journal-title":"Nat Cell Biol"},{"issue":"37","key":"ref58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1074\/jbc.273.37.24057","article-title":"p35, the neuronal-specific activator of cyclin-dependent kinse 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway","volume":"273","author":"GN Patrick","year":"1998","journal-title":"The Journal of biological chemistry"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/dgd.12138","article-title":"Cdk5 regulates multiple cellular events in neural development, function and disease","volume":"56","author":"T Kawauchi","year":"2014","journal-title":"Dev Growth Differ"},{"issue":"21","key":"ref60","first-page":"8","article-title":"Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevence to neurotoxic insults in Alzheimer's disease","volume":"20","author":"KH Sun","year":"2009","journal-title":"Mol Biol Cell"},{"issue":"5","key":"ref61","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.molcel.2010.11.035","article-title":"The proapoptotic function of Noxa in human leukemia cells is regulated by the kinase Cdk5 and by glucose","volume":"40","author":"XH Lowman","year":"2010","journal-title":"Molecular cell"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0143685","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T21:53:16Z","timestamp":1599861196000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0143685"}},"subtitle":[],"editor":[{"given":"Salvatore V","family":"Pizzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":61,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0143685","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,25]]}}}